Literature DB >> 15716418

Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.

Jenny Nyberg1, Michelle F Anderson, Björn Meister, Ann-Marie Alborn, Anna-Karin Ström, Anke Brederlau, Ann-Christin Illerskog, Ola Nilsson, Timothy J Kieffer, Max Albert Hietala, Anne Ricksten, Peter S Eriksson.   

Abstract

The hippocampal dentate gyrus (DG) is an area of active proliferation and neurogenesis within the adult brain. The molecular events controlling adult cell genesis in the hippocampus essentially remain unknown. It has been reported previously that adult male and female rats from the strains Sprague Dawley (SD) and spontaneously hypertensive (SHR) have a marked difference in proliferation rates of cells in the hippocampal DG. To exploit this natural variability and identify potential regulators of cell genesis in the hippocampus, hippocampal gene expression from male SHR as well as male and female SD rats was analyzed using a cDNA array strategy. Hippocampal expression of the gene-encoding glucose-dependent insulinotropic polypeptide (GIP) varied strongly in parallel with cell-proliferation rates in the adult rat DG. Moreover, robust GIP immunoreactivity could be detected in the DG. The GIP receptor is expressed by cultured adult hippocampal progenitors and throughout the granule cell layer of the DG, including progenitor cells. Thus, these cells have the ability to respond to GIP. Indeed, exogenously delivered GIP induced proliferation of adult-derived hippocampal progenitors in vivo as well as in vitro, and adult GIP receptor knock-out mice exhibit a significantly lower number of newborn cells in the hippocampal DG compared with wild-type mice. This investigation demonstrates the presence of GIP in the brain for the first time and provides evidence for a regulatory function for GIP in progenitor cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716418      PMCID: PMC6725940          DOI: 10.1523/JNEUROSCI.4920-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

Review 1.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

2.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

3.  Mitogen- and stress-activated kinases regulate progenitor cell proliferation and neuron development in the adult dentate gyrus.

Authors:  Yun-Sik Choi; Kate Karelina; Diego Alzate-Correa; Kari R Hoyt; Soren Impey; J Simon Arthur; Karl Obrietan
Journal:  J Neurochem       Date:  2012-10-25       Impact factor: 5.372

Review 4.  Assessment of genome and proteome profiles in cocaine abuse.

Authors:  Scott E Hemby
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

Review 5.  Bidirectional metabolic regulation of neurocognitive function.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  Neurobiol Learn Mem       Date:  2011-01-12       Impact factor: 2.877

Review 6.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

7.  Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Jayasankar Kosaraju; R M Damian Holsinger; Lixia Guo; Kin Yip Tam
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

Review 8.  Cocainomics: new insights into the molecular basis of cocaine addiction.

Authors:  Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2010-03       Impact factor: 4.147

9.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

10.  Hormonal regulators of appetite.

Authors:  Juliana Austin; Daniel Marks
Journal:  Int J Pediatr Endocrinol       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.